logo-loader

Actelion Ltd.

Receive alerts
Market:
PINK
Market Cap:
$29.14 billion
Price
278.50 USD
Change
0.00%
52 weeks high
286.30
52 weeks low
145.51

In brief

Actelion Ltd is a Swiss biopharmaceutical holding company that focuses on the discovery, development and commercialization of small molecule drugs. The Company has four approved drugs on the market: Tracleer, an oral dual endothelin receptor antagonist; Veletri, a prostanoid vasodilator; Ventavis, an inhaled formulation of iloprost, and Zavesca, an oral treatment for type 1 Gaucher disease.